Abbott Labs’ surprise guidance bump is a major positive for its shareholders

Products You May Like

An Abbott Labs employee gets the BinaxNOW rapid Covid-19 antigen test at her workplace.
Abbott Labs

Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by the medical device maker not seen in a first quarter since 2016.

Products You May Like

Articles You May Like

How Project 2025 could impact your tax bracket and capital gains under a second Trump term
Stocks making the biggest moves after hours: Alphabet, Tesla, Visa and more
Education Department to pause student loan payments for millions amid legal battle
NBA sends media terms to Warner Bros. Discovery, officially starting five-day match period
GM slows its EV plans again even as sales grow

Leave a Reply

Your email address will not be published. Required fields are marked *